As Alleghany (Y) Shares Declined, Mcclain Value Management Boosted Its Position; As Bristol Myers Squibb Co (BMY) Stock Declined, Ims Capital Management Has Cut Holding by $377,433

February 23, 2018 - By Clifton Ray

Mcclain Value Management Llc increased its stake in Alleghany Corp (Y) by 22.24% based on its latest 2017Q3 regulatory filing with the SEC. Mcclain Value Management Llc bought 1,450 shares as the company’s stock declined 10.28% while stock markets rallied. The institutional investor held 7,969 shares of the property-casualty insurers company at the end of 2017Q3, valued at $4.42 million, up from 6,519 at the end of the previous reported quarter. Mcclain Value Management Llc who had been investing in Alleghany Corp for a number of months, seems to be bullish on the $9.33 billion market cap company. The stock increased 2.49% or $14.72 during the last trading session, reaching $606.46. About 87,433 shares traded or 10.94% up from the average. Alleghany Corporation (NYSE:Y) has risen 7.94% since February 23, 2017 and is uptrending. It has underperformed by 8.76% the S&P500.

Ims Capital Management decreased its stake in Bristol Myers Squibb Co (BMY) by 21.1% based on its latest 2017Q3 regulatory filing with the SEC. Ims Capital Management sold 5,991 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 22,399 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.43 million, down from 28,390 at the end of the previous reported quarter. Ims Capital Management who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $107.65 billion market cap company. The stock decreased 0.89% or $0.59 during the last trading session, reaching $65.94. About 6.53M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 23, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Investors sentiment increased to 1.14 in 2017 Q3. Its up 0.22, from 0.92 in 2017Q2. It increased, as 28 investors sold Y shares while 89 reduced holdings. 34 funds opened positions while 99 raised stakes. 12.56 million shares or 0.02% more from 12.56 million shares in 2017Q2 were reported. Retirement Of Alabama owns 29,520 shares. Central Securities stated it has 1.99% in Alleghany Corporation (NYSE:Y). 976 were accumulated by Vident Advisory Ltd Liability Corp. Hillsdale Inv Mngmt has 0% invested in Alleghany Corporation (NYSE:Y). Suntrust Banks stated it has 1,668 shares or 0% of all its holdings. 318,454 were accumulated by Natl Bank Of Ny Mellon. 21,100 were accumulated by State Teachers Retirement. Cornerstone Advsrs has 196 shares. Wells Fargo And Mn holds 31,069 shares. 165,844 were accumulated by Principal Fincl Group. Texas Permanent School Fund holds 0.08% of its portfolio in Alleghany Corporation (NYSE:Y) for 11,271 shares. Independent Order Of Foresters holds 0.12% or 260 shares. Rdl Inc reported 0.68% of its portfolio in Alleghany Corporation (NYSE:Y). Massachusetts-based Rhumbline Advisers has invested 0.04% in Alleghany Corporation (NYSE:Y). Cibc Asset Mngmt stated it has 912 shares.

Among 2 analysts covering Alleghany (NYSE:Y), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Alleghany had 3 analyst reports since June 16, 2016 according to SRatingsIntel. As per Monday, September 11, the company rating was upgraded by JMP Securities. Citigroup upgraded Alleghany Corporation (NYSE:Y) rating on Thursday, June 16. Citigroup has “Buy” rating and $43 target. The rating was maintained by JMP Securities with “Hold” on Thursday, February 22.

Mcclain Value Management Llc, which manages about $543.84M and $71.05M US Long portfolio, decreased its stake in Allegheny Technologies Inc (NYSE:ATI) by 113,482 shares to 235,712 shares, valued at $5.63 million in 2017Q3, according to the filing. It also reduced its holding in Fnfv Group Of Fidelity Nationa (NYSE:FNFV) by 64,858 shares in the quarter, leaving it with 174,658 shares, and cut its stake in Enanta Pharmaceuticals Inc (NASDAQ:ENTA).

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Edge Wealth Mngmt Ltd Com holds 0.01% or 770 shares. First Foundation Advsr stated it has 30,482 shares or 0.11% of all its holdings. Ar Asset Management stated it has 59,924 shares or 1.51% of all its holdings. New York State Teachers Retirement System, a New York-based fund reported 2.75M shares. Meridian Mgmt Co accumulated 51,185 shares or 1.62% of the stock. Stock Yards Financial Bank Tru Company, Kentucky-based fund reported 53,454 shares. Covington Capital Mgmt owns 58,192 shares. Diligent Invsts Ltd owns 15,552 shares for 0.72% of their portfolio. Aviance Prns Ltd Liability Company holds 0.33% or 15,296 shares in its portfolio. Messner Smith Theme Value Inv Mgmt Limited Ca holds 0.51% or 5,123 shares. 318,626 are held by Country Trust Bancshares. Perella Weinberg Prtnrs Capital Lp invested in 0.54% or 101,546 shares. The Colorado-based Obermeyer Wood Investment Counsel Lllp has invested 0.11% in Bristol-Myers Squibb Company (NYSE:BMY). Adirondack Tru Co owns 24,933 shares. State Of New Jersey Common Pension Fund D invested in 0.42% or 1.65M shares.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on April, 26. They expect $0.87 earnings per share, up 3.57% or $0.03 from last year’s $0.84 per share. BMY’s profit will be $1.42 billion for 18.95 P/E if the $0.87 EPS becomes a reality. After $0.68 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts 27.94% EPS growth.

Ims Capital Management, which manages about $164.74M and $156.00M US Long portfolio, upped its stake in Altria Group Inc (NYSE:MO) by 5,045 shares to 10,525 shares, valued at $667,000 in 2017Q3, according to the filing.

Since September 6, 2017, it had 1 buying transaction, and 2 insider sales for $646,385 activity. 4,000 shares valued at $249,187 were bought by Samuels Theodore R. II on Friday, December 15. 9,340 shares were sold by Caldarella Joseph C, worth $560,400.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: